Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Halfvarson

Showing results (231-240 of 244) with videos related to

Pageof 25
Sort By:
Gut|January 25, 2018
Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD studyJohan Burisch, Gediminas Kiudelis, Limas Kupcinskas, et al.
United European Gastroenterology Journal|July 28, 2020
The use of 5-aminosalicylate for patients with Crohn's disease in a prospective European inception cohort with 5 years follow-up - an Epi-IBD studyJohan Burisch, Daniel Bergemalm, Jonas Halfvarson, et al.
Journal of Crohn'S & Colitis|October 6, 2018
Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort-An Epi-IBD StudyJohan Burisch, Konstantinos H Katsanos, Dimitrios K Christodoulou, et al.
Inflammatory Bowel Diseases|December 2, 2014
Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom StudyJohan Burisch, Hillel Vardi, Natalia Pedersen, et al.
Nature Communications|September 14, 2016
Erratum: A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitisManuel A Rivas, Daniel Graham, Patrick Sulem, et al.
Journal of Crohn'S & Colitis|June 3, 2017
Occurrence of Anaemia in the First Year of Inflammatory Bowel Disease in a European Population-based Inception Cohort-An ECCO-EpiCom StudyJohan Burisch, Zsuzsanna Vegh, Konstantinnos H Katsanos, et al.
JAMA|February 27, 2019
Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel DiseaseGareth J Walker, James W Harrison, Graham A Heap, et al.
Gastroenterology|April 30, 2013
Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studiesDavid Ellinghaus, Hu Zhang, Sebastian Zeissig, et al.
Nature Genetics|March 16, 2010
Genome-wide association identifies multiple ulcerative colitis susceptibility lociDermot P B McGovern, Agnès Gardet, Leif Törkvist, et al.
Nature Genetics|September 15, 2014
HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressantsGraham A Heap, Michael N Weedon, Claire M Bewshea, et al.
Pageof 25

Showing results (231-240 of 244) with videos related to

Sort By:
Pageof 25
Gut|January 25, 2018
Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD studyJohan Burisch, Gediminas Kiudelis, Limas Kupcinskas, et al.
United European Gastroenterology Journal|July 28, 2020
The use of 5-aminosalicylate for patients with Crohn's disease in a prospective European inception cohort with 5 years follow-up - an Epi-IBD studyJohan Burisch, Daniel Bergemalm, Jonas Halfvarson, et al.
Journal of Crohn'S & Colitis|October 6, 2018
Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort-An Epi-IBD StudyJohan Burisch, Konstantinos H Katsanos, Dimitrios K Christodoulou, et al.
Inflammatory Bowel Diseases|December 2, 2014
Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom StudyJohan Burisch, Hillel Vardi, Natalia Pedersen, et al.
Nature Communications|September 14, 2016
Erratum: A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitisManuel A Rivas, Daniel Graham, Patrick Sulem, et al.
Journal of Crohn'S & Colitis|June 3, 2017
Occurrence of Anaemia in the First Year of Inflammatory Bowel Disease in a European Population-based Inception Cohort-An ECCO-EpiCom StudyJohan Burisch, Zsuzsanna Vegh, Konstantinnos H Katsanos, et al.
JAMA|February 27, 2019
Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel DiseaseGareth J Walker, James W Harrison, Graham A Heap, et al.
Gastroenterology|April 30, 2013
Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studiesDavid Ellinghaus, Hu Zhang, Sebastian Zeissig, et al.
Nature Genetics|March 16, 2010
Genome-wide association identifies multiple ulcerative colitis susceptibility lociDermot P B McGovern, Agnès Gardet, Leif Törkvist, et al.
Nature Genetics|September 15, 2014
HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressantsGraham A Heap, Michael N Weedon, Claire M Bewshea, et al.
Pageof 25